New Tool for Assessment of Pharmaceutical Market

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
New Tool for Assessment of Pharmaceutical Market Performance is Now Available to Financial Analysts

HORSHAM, Pa., Jan. 15, 2016 (GLOBE NEWSWIRE) -- Symphony Health Solutions (SHS), a provider of high-value market research, analytics, and technology solutions for life sciences manufacturers, payers, and providers, today announced that IDV® (Integrated Dataverse), an exciting new big data solution that provides market-leading coverage and insights to the drivers of pharmaceutical demand, is now broadly available for financial industry analysts as well as life sciences manufacturers. IDV®, the sole source of U.S. prescription-volume market data on the Bloomberg Professional service, went live today with the first full week of January data. Financial industry analysts will benefit from this data as part of their existing Bloomberg Professional service subscription.

IDV®, a HIPAA-compliant platform, is the result of substantial data and technology investments made by SHS to provide the most accurate and complete picture of the pharmaceutical market. “We know that both our life sciences and financial community clients are most interested in understanding the volume of product that is actually sold in the market, not just what might be languishing in pharmacy bins,” explained Don Otterbein, SVP Marketing & Product Management and GM, Consulting & Services. “We built IDV to tell the full story of the patient journey – from diagnosis, to prescription, to payer influence, and finally to patient influence. Do patients actually buy what is prescribed, and why or why not?”

Life sciences manufacturers and financial analysts alike can now view the same level of information and detail in assessing market performance of a brand. As the foundation for all SHS data products, IDV® offers a complete picture of a given health event across prescriber, payer, and patient dimensions with analytics to answer key questions and facilitate critical business and commercial processes. Taking a holistic approach to analyzing health events enables a better understanding of both the clinical and financial decisions that impact the performance of brands.

Access to IDV® is simple and efficient with delivery via PHAST, the company’s audit suite, or Symphony HealthCloud™ and Vantage TM Applications , the company’s proprietary cloud-based platform and analytic solutions suites.  Bloomberg clients can access Symphony Health Solutions data on the Bloomberg Professional service by typing "BI PHRMX <GO>" and clicking on “Drug Explorer.”  Bloomberg is also the only re-distributor of Symphony Health’s Pharmaceutical Audit Suite (PHAST) to the financial industry.

For more information about IDV®, view the info video or visit the SHS website at www.symphonyhealth.com . 

About IDV® Combining SHS’s vast claims resources and rich point-of-sale retail prescription data, IDV® is the industry’s most complete and interconnected source of healthcare data. SHS utilizes payment processing systems to capture the full claims lifecycle and more accurately depict prescription activity.  By connecting physician, pharmacy, anonymized patient, medical and hospital data, IDV® reveals real-world behaviors and illuminates increasingly complex therapy decisions. With true transaction-level integration across all dimensions, IDV® combines different facets of information, allowing a view of a single health event from many different angles in support of increasingly sophisticated insight-driven strategies and programs.  

About Symphony Health Solutions Symphony Health Solutions is a leading provider of high-value data, analytics, technology solutions and actionable insights for healthcare and life sciences manufacturers, payers and providers. The company helps clients drive revenue growth and commercial effectiveness, while adapting to the transformation of the healthcare ecosystem, by integrating a broad set of patient, prescriber, payer and clinical data together with primary and secondary health research, analytics and consulting. Symphony delivers a comprehensive perspective on the real dynamics that drive business in the healthcare and life sciences markets. For more information, visit www.symphonyhealth.com .

For media information, please contact: Heather Varela, Symphony Health Solutions heather.varela@symphonyhealth.com +1 602.463.7838

Scroll down for more posts ▼

Top 10 Most Recent News Articles

CAE Boosts Fiscal 2027 Outlook; Transformation On Track

Updated Category News Views 116

Revenue's down by a hair, but it's not as bleak as it seems. CAE Inc. (NASDAQ:CAE) just put its cards on the table for Q2 of fiscal 2027, and there's a mixed bag for us investors to chew over. Revenue dipped 2.6% year-over-year to $1,204.7 million. But hey, their adjusted EPS has climbed up to $0.33, a step up from $0.28 last year, which is a good sign of something right...

Continue Reading
Ingram Micro Joins S&P SmallCap 600 Amid M&A Moves

Updated Category News Views 87

Market Shufflin’ as Ingram Micro Steps In The constant ebb and flow of the stock market got right interesting with Ingram Micro Holding Corp. (NYSE: INGM) slated to crawl into the S&P SmallCap 600. This dance change-up is all thanks to Viatris Inc. (NASD: VTRS) looking to wrap up its acquisition of Pacira BioSciences (NASD: PCRX). With this deal sealing the fate of...

Continue Reading
'Luz de las Naciones' Event: A Cultural Milestone

Updated Category News Views 67

A Vibrant Showcase of Culture and Faith Grab your seatbelt, because when you hear about a cultural event lighting up the scene, especially one backed by The Church of Jesus Christ of Latter-day Saints, it means something's brewing. We're diving headfirst into 'Luz de las Naciones,' a celebration that's keeping its promise to highlight Latin America's zest and vibrant...

Continue Reading
Elron Ventures Advances Dual-Use Tech Investment Plans

Updated Category News Views 19

A Strategic Dance through Conferences Elron Ventures is gearing up for an action-packed November slate, aiming to flaunt its prowess in investment across burgeoning tech fields like Defense Tech, Deep Tech, Cybersecurity, and AI. Now, any seasoned investor knows these are the buzzy sectors that could just be the workhorses pulling the future market cart. But what makes...

Continue Reading
GFL's Big Share Conversion: Impact and Implications

Updated Category News Views 0

Unpacking GFL Environmental's Share Conversion Here's a doozy straight from the gritty world of finance: GFL Environmental Inc. (NYSE: GFL) has announced a hefty conversion of Series A Preferred Shares into a whopping 6,219,896 subordinate voting shares. That's right, those Series A Preferred Shares, helmed by HPS Investment Partners, LLC, are now converted and sold in a...

Continue Reading
China's Double 11 Fest Rings in $264B in 2026

Updated Category News Views 8

Shifting Gears at the 2026 Double 11 Festival You blinked, and another record was shattered. China's "Double 11" Shopping Festival, with its rhythmic frenzy and relentless countdowns, clocked a staggering RMB 1,776.4 billion this year—roughly US$264.4 billion. This ain't no ordinary sale, it's a financial juggernaut, folks. As these platforms duke it out for every yuan,...

Continue Reading
DarioHealth Eyes Growth with Rising Revenue and Reduced Costs

Updated Category News Views 0

Quarterly Earnings Reflect Strategic Forward Movement This quarter, DarioHealth (NASDAQ: DRIO) decided to crank up the volume on its long-haul strategy. They've managed a respectable 6% revenue increase over last year, clocking in at $5.3 million for the third quarter of 2026. It's a slight nudge up from the previous quarter too, where they sat at $5.2 million. Not...

Continue Reading
Can BWIN, CCC, PCRX Deals Really Serve Shareholders?

Updated Category News Views 28

Shareholder Stakes: Caught in Controversy Well, here we go again. These days, it seems like shareholder lawsuits are cropping up as regularly as sunrise. We've got Halper Sadeh LLC on a warpath, targeting potential legal missteps in the megadeals involving Baldwin Group (NASDAQ:BWIN), CCC Intelligent Solutions Holdings (NASDAQ:CCC), and Pacira BioSciences (NASDAQ:PCRX)....

Continue Reading
Eli Radiopharma Clinches Big Series A, Eyes Milestones

Updated Category News Views 103

Making Waves in Radiopharmaceuticals Some days, it's not just about the numbers—it’s about the shift in an entire field. Eli Radiopharma just closed a grand RMB 400 million Series A financing, paving a path that could redefine radiopharmaceuticals. Kinfolk over at Huagai Capital led the charge, teaming up with Bayland Capital and a throng of other backers. They’re...

Continue Reading
BSR REIT's Q3 2026 Financials: Strategic Progress Made

Updated Category News Views 57

BSR REIT Hits Strategic Milestones in Q3 Here's a bit of exciting news hitting us from BSR Real Estate Investment Trust. They've dropped their financial results for the third quarter of 2026. Packed with some solid gains, this quarter wasn't just about the numbers—it was about the moves they've been making underneath it all. So, let's break down what they're up to, and...

Continue Reading

Top 5 Most Recently Viewed Articles

Indy Autonomous Challenge Unveils Multicar Racing at CES 2025

Updated Category News Views 312

Indy Autonomous Challenge Returns at CES 2025 The Indy Autonomous Challenge (IAC), a global leader in high-speed autonomy, is poised for an exciting return to CES 2025 with groundbreaking developments, including the introduction of multicar racing and advancements in physical AI. This event, taking place in January 2025 at the Las Vegas Motor Speedway, promises a...

Continue Reading
Veris Residential, Inc. Sets Webcast for Q2 2025 Financials

Updated Category News Views 200

Veris Residential, Inc. Plans Webcast for Q2 Financial Results Veris Residential, Inc. provides an exciting update for shareholders and potential investors. The company has announced it will host a webcast for its second quarter 2025 financial results. This marks an important opportunity for stakeholders to gain insights into the company's performance and future...

Continue Reading
Bank Expert Shares Tips for Effortless Checking Setup

Updated Category News Views 129

Streamlining Your Checking Account Setup Tossing out the right prep can turn opening a checking account from a headache to a breeze. Banking luminary Abigail White spills the beans in a HelloNation piece, shedding light on how getting your ducks in a row with documents and features puts you in the driver’s seat of financial well-being. The Basics: Identification and...

Continue Reading
Serabi Gold Announces Robust Mid-Year Financial Performance

Updated Category News Views 207

Serabi Gold Reports Strong Interim Results for 2024 Serabi Gold plc (LSE: SRB, TSX: SBI) has unveiled its unaudited financial results for the first half of 2024, demonstrating impressive growth and strategic investments during this period. Strong Financial Performance Clive Line, the Chief Financial Officer of Serabi Gold, emphasized the company's financial successes in...

Continue Reading
Innovative Strategies in Drug Development: A New Era with BullFrog AI

Updated Category News Views 190

Transforming Drug Development with Innovative AI Solutions From target discovery to trial optimization, bfLEAP™ empowers biopharma teams to predict therapeutic success with greater confidence. In a market valued over $200 billion and saturated with black-box AI, BullFrog AI's bfLEAP™ stands out by offering biologically grounded analytics that steer strategic...

Continue Reading